Quest Diagnostics (DGX) Financials: Revenue & Earnings
DGX$251.08+5.46 +2.22%
$27.71B
Market Cap
23.83
P/E
22.21
Forward P/E
41
Score
Quest Diagnostics (DGX) Financials: Revenue & Earnings
DGX price $251.08 +5.46 +2.22%
- Ticker
- DGX
- Price
- $251.08
- Change
- +5.46 +2.22%
- Market cap ?
- $27.71B
- P/E ?
- 23.83
- Forward P/E ?
- 22.21
- Dividend yield ?
- 1.39%
- Beta ?
- 0.54
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Stocklytics score
- 41
- Value
- 36
- Quality
- 50
- Growth
- 36
Stocklytics score rationale: value 36, quality 50, growth 36.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 7515000000 | 7709000000 | 7531000000 | 7726000000 | 9437000000 | 10788000000 | 9883000000 | 9252000000 | 9872000000 | 11035000000 |
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily…
Earnings and financials
Quest Diagnostics Incorporated (DGX) trades at $251.08, with a market cap of $27.71B and a trailing P/E of 23.83. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 7515000000 | 7709000000 | 7531000000 | 7726000000 | 9437000000 | 10788000000 | 9883000000 | 9252000000 | 9872000000 | 11035000000 |
Insights · Dividends · Forecast · Financials · Learn